Guardant Health, Inc. Common Stock

GHNASDAQUSD
90.13 USD
3.70 (3.94%)🟢LIVE (AS OF 01:02 PM EDT)
🟢Market: OPEN
Open?$92.68
High?$93.97
Low?$88.94
Prev. Close?$93.83
Volume?476.1K
Avg. Volume?2.0M
VWAP?$91.03
Rel. Volume?0.24x
Bid / Ask
Bid?$90.74 × 100
Ask?$97.00 × 400
Spread?$6.26
Midpoint?$93.87
Valuation & Ratios
Market Cap?12.3B
Shares Out?131.2M
Float?126.2M
Float %?96.2%
P/E Ratio?N/A
P/B Ratio?-123.94
EPS?-$3.17
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.84Strong
Quick Ratio?4.56Strong
Cash Ratio?1.25Strong
Debt/Equity?-15.14Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
-123.94CHEAP
P/S?
12.53HIGH
P/FCF?
N/A
EV/EBITDA?
-33.8CHEAP
EV/Sales?
13.68HIGH
Returns & Efficiency
ROE?
419.2%STRONG
ROA?
-20.7%WEAK
Cash Flow & Enterprise
FCF?$-233066000
Enterprise Value?$13.4B
Related Companies
Loading...
News
Profile
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Employees
2.5K
Market Cap
12.3B
Industry
SERVICES-MEDICAL LABORATORIES
Listed
2018-10-04
Address
3100 HANOVER STREET
PALO ALTO, CA 94304
Phone: 855-698-8887